25 XP   0   0   10

Prescient Therapeutics Ltd
Buy, Hold or Sell?

Let's analyse Prescient Therapeutics Ltd together

PenkeI guess you are interested in Prescient Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Prescient Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Prescient Therapeutics Ltd

I send you an email if I find something interesting about Prescient Therapeutics Ltd.

Quick analysis of Prescient Therapeutics Ltd (30 sec.)










What can you expect buying and holding a share of Prescient Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.03
Expected worth in 1 year
A$0.02
How sure are you?
43.6%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-7.9%

For what price can you sell your share?

Current Price per Share
A$0.05
Expected price per share
A$0.048 - A$0.066
How sure are you?
50%

1. Valuation of Prescient Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.05

Intrinsic Value Per Share

A$-0.25 - A$-0.13

Total Value Per Share

A$-0.22 - A$-0.10

2. Growth of Prescient Therapeutics Ltd (5 min.)




Is Prescient Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$14.8m$13.6m$2.7m16.6%

How much money is Prescient Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m-$1.3m-$821.9k-38.3%
Net Profit Margin-296.5%-174.5%--

How much money comes from the company's main activities?

3. Financial Health of Prescient Therapeutics Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#599 / 1007

Most Revenue
#463 / 1007

Most Profit
#411 / 1007

Most Efficient
#666 / 1007

What can you expect buying and holding a share of Prescient Therapeutics Ltd? (5 min.)

Welcome investor! Prescient Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of Prescient Therapeutics Ltd.

What can you expect buying and holding a share of Prescient Therapeutics Ltd?

First you should know what it really means to hold a share of Prescient Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Prescient Therapeutics Ltd is A$0.046. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Prescient Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Prescient Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.03. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Prescient Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-6.4%0.00-5.8%0.00-3.0%0.00-2.8%0.00-2.1%
Usd Book Value Change Per Share0.00-6.1%0.00-1.3%0.002.7%0.001.4%0.001.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-6.1%0.00-1.3%0.002.7%0.001.4%0.001.0%
Usd Price Per Share0.04-0.05-0.10-0.07-0.06-
Price to Earnings Ratio-3.45--5.80--20.73--17.19--18.87-
Price-to-Total Gains Ratio-14.41--3,480.74--722.40--1,071.46-23,301.38-
Price to Book Ratio2.21-2.62-6.16-4.81-6.10-
Price-to-Total Gains Ratio-14.41--3,480.74--722.40--1,071.46-23,301.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.030222
Number of shares33088
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (33088 shares)-19.7320.77
Gains per Year (33088 shares)-78.9283.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-79-8908373
20-158-1680166156
30-237-2470249239
40-316-3260332322
50-395-4050415405
60-474-4840499488
70-552-5630582571
80-631-6420665654
90-710-7210748737
100-789-8000831820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%0.039.00.00.0%4.096.06.03.8%
Book Value Change Per Share1.02.00.033.3%2.06.03.018.2%4.08.07.021.1%17.014.08.043.6%37.036.033.034.9%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.039.00.0%0.00.0106.00.0%
Total Gains per Share1.02.00.033.3%2.06.03.018.2%4.08.07.021.1%17.014.08.043.6%37.036.033.034.9%

Fundamentals of Prescient Therapeutics Ltd

About Prescient Therapeutics Ltd

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. The company was incorporated in 1986 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-04-30 13:09:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Prescient Therapeutics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Prescient Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -186.6% means that $-1.87 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Prescient Therapeutics Ltd:

  • The MRQ is -186.6%. The company is making a huge loss. -2
  • The TTM is -296.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-186.6%TTM-296.5%+109.9%
TTM-296.5%YOY-174.5%-122.0%
TTM-296.5%5Y-210.8%-85.8%
5Y-210.8%10Y-949.3%+738.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-186.6%-207.2%+20.6%
TTM-296.5%-218.5%-78.0%
YOY-174.5%-282.4%+107.9%
5Y-210.8%-432.2%+221.4%
10Y-949.3%-593.8%-355.5%
1.1.2. Return on Assets

Shows how efficient Prescient Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • -14.6% Return on Assets means that Prescient Therapeutics Ltd generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Prescient Therapeutics Ltd:

  • The MRQ is -14.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.6%TTM-12.2%-2.4%
TTM-12.2%YOY-9.5%-2.7%
TTM-12.2%5Y-9.8%-2.4%
5Y-9.8%10Y-9.8%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.6%-13.2%-1.4%
TTM-12.2%-12.6%+0.4%
YOY-9.5%-11.5%+2.0%
5Y-9.8%-13.7%+3.9%
10Y-9.8%-15.5%+5.7%
1.1.3. Return on Equity

Shows how efficient Prescient Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • -16.0% Return on Equity means Prescient Therapeutics Ltd generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Prescient Therapeutics Ltd:

  • The MRQ is -16.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.0%TTM-13.5%-2.5%
TTM-13.5%YOY-10.1%-3.4%
TTM-13.5%5Y-10.3%-3.1%
5Y-10.3%10Y-10.5%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.0%-16.7%+0.7%
TTM-13.5%-15.8%+2.3%
YOY-10.1%-14.4%+4.3%
5Y-10.3%-19.0%+8.7%
10Y-10.5%-19.9%+9.4%

1.2. Operating Efficiency of Prescient Therapeutics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Prescient Therapeutics Ltd is operating .

  • Measures how much profit Prescient Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -205.4% means the company generated $-2.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Prescient Therapeutics Ltd:

  • The MRQ is -205.4%. The company is operating very inefficient. -2
  • The TTM is -320.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-205.4%TTM-320.6%+115.2%
TTM-320.6%YOY-181.5%-139.2%
TTM-320.6%5Y-221.7%-99.0%
5Y-221.7%10Y-466.2%+244.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-205.4%-286.5%+81.1%
TTM-320.6%-229.1%-91.5%
YOY-181.5%-288.4%+106.9%
5Y-221.7%-480.7%+259.0%
10Y-466.2%-624.7%+158.5%
1.2.2. Operating Ratio

Measures how efficient Prescient Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.05 means that the operating costs are $3.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 3.054. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.209. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.054TTM4.209-1.154
TTM4.209YOY2.564+1.644
TTM4.2095Y2.954+1.255
5Y2.95410Y12.281-9.327
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0543.231-0.177
TTM4.2093.307+0.902
YOY2.5643.774-1.210
5Y2.9545.667-2.713
10Y12.2817.558+4.723

1.3. Liquidity of Prescient Therapeutics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Prescient Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.26 means the company has $10.26 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 10.256. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.556. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.256TTM11.556-1.300
TTM11.556YOY19.725-8.169
TTM11.5565Y26.782-15.226
5Y26.78210Y19.968+6.814
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2563.890+6.366
TTM11.5564.182+7.374
YOY19.7255.343+14.382
5Y26.7826.135+20.647
10Y19.9686.453+13.515
1.3.2. Quick Ratio

Measures if Prescient Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 15.72 means the company can pay off $15.72 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 15.724. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 18.568. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ15.724TTM18.568-2.844
TTM18.568YOY19.024-0.456
TTM18.5685Y18.444+0.124
5Y18.44410Y14.211+4.233
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.7243.528+12.196
TTM18.5684.059+14.509
YOY19.0245.390+13.634
5Y18.4446.138+12.306
10Y14.2116.488+7.723

1.4. Solvency of Prescient Therapeutics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Prescient Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Prescient Therapeutics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Prescient Therapeutics Ltd assets are financed with 8.7% credit (debt) and the remaining percentage (100% - 8.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 0.087. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.077. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.087TTM0.077+0.010
TTM0.077YOY0.045+0.032
TTM0.0775Y0.047+0.030
5Y0.04710Y0.052-0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0870.339-0.252
TTM0.0770.337-0.260
YOY0.0450.273-0.228
5Y0.0470.368-0.321
10Y0.0520.391-0.339
1.4.2. Debt to Equity Ratio

Measures if Prescient Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 9.5% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 0.095. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.086. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.095TTM0.086+0.009
TTM0.086YOY0.048+0.038
TTM0.0865Y0.050+0.035
5Y0.05010Y0.056-0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0950.388-0.293
TTM0.0860.403-0.317
YOY0.0480.342-0.294
5Y0.0500.432-0.382
10Y0.0560.461-0.405

2. Market Valuation of Prescient Therapeutics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Prescient Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • A PE ratio of -3.45 means the investor is paying $-3.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Prescient Therapeutics Ltd:

  • The EOD is -2.559. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.449. Based on the earnings, the company is expensive. -2
  • The TTM is -5.803. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.559MRQ-3.449+0.890
MRQ-3.449TTM-5.803+2.354
TTM-5.803YOY-20.725+14.923
TTM-5.8035Y-17.186+11.383
5Y-17.18610Y-18.871+1.685
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.559-2.249-0.310
MRQ-3.449-2.553-0.896
TTM-5.803-2.669-3.134
YOY-20.725-4.107-16.618
5Y-17.186-6.247-10.939
10Y-18.871-6.499-12.372
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Prescient Therapeutics Ltd:

  • The EOD is -2.658. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.582. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.782. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.658MRQ-3.582+0.924
MRQ-3.582TTM-5.782+2.200
TTM-5.782YOY-20.341+14.558
TTM-5.7825Y-19.872+14.090
5Y-19.87210Y-19.467-0.405
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.658-2.858+0.200
MRQ-3.582-3.288-0.294
TTM-5.782-3.552-2.230
YOY-20.341-5.560-14.781
5Y-19.872-8.326-11.546
10Y-19.467-8.881-10.586
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Prescient Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.21 means the investor is paying $2.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Prescient Therapeutics Ltd:

  • The EOD is 1.638. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.208. Based on the equity, the company is underpriced. +1
  • The TTM is 2.625. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.638MRQ2.208-0.570
MRQ2.208TTM2.625-0.417
TTM2.625YOY6.157-3.532
TTM2.6255Y4.810-2.185
5Y4.81010Y6.102-1.293
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6381.929-0.291
MRQ2.2082.090+0.118
TTM2.6252.091+0.534
YOY6.1572.881+3.276
5Y4.8103.545+1.265
10Y6.1023.936+2.166
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Prescient Therapeutics Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Prescient Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.001-79%0.002-324%0.001-550%0.001-743%
Book Value Per Share--0.0280.031-9%0.026+9%0.023+22%0.017+68%
Current Ratio--10.25611.556-11%19.725-48%26.782-62%19.968-49%
Debt To Asset Ratio--0.0870.077+13%0.045+94%0.047+85%0.052+67%
Debt To Equity Ratio--0.0950.086+11%0.048+99%0.050+89%0.056+70%
Dividend Per Share----0%-0%-0%-0%
Eps---0.004-0.004-10%-0.002-53%-0.002-56%-0.001-68%
Free Cash Flow Per Share---0.004-0.004-7%-0.002-48%-0.002-53%-0.002-64%
Free Cash Flow To Equity Per Share---0.004-0.001-80%0.003-250%0.001-556%0.000-2154%
Gross Profit Margin--1.2921.2920%1.318-2%1.217+6%1.176+10%
Intrinsic Value_10Y_max---0.128--------
Intrinsic Value_10Y_min---0.249--------
Intrinsic Value_1Y_max---0.007--------
Intrinsic Value_1Y_min---0.013--------
Intrinsic Value_3Y_max---0.026--------
Intrinsic Value_3Y_min---0.049--------
Intrinsic Value_5Y_max---0.050--------
Intrinsic Value_5Y_min---0.097--------
Market Cap37044720.000-35%49929840.00065902020.000-24%123817950.000-60%90005106.316-45%73734273.231-32%
Net Profit Margin---1.866-2.965+59%-1.745-6%-2.108+13%-9.493+409%
Operating Margin---2.054-3.206+56%-1.815-12%-2.217+8%-4.662+127%
Operating Ratio--3.0544.209-27%2.564+19%2.954+3%12.281-75%
Pb Ratio1.638-35%2.2082.625-16%6.157-64%4.810-54%6.102-64%
Pe Ratio-2.559+26%-3.449-5.803+68%-20.725+501%-17.186+398%-18.871+447%
Price Per Share0.046-35%0.0620.082-24%0.154-60%0.112-45%0.092-32%
Price To Free Cash Flow Ratio-2.658+26%-3.582-5.782+61%-20.341+468%-19.872+455%-19.467+443%
Price To Total Gains Ratio-10.689+26%-14.407-3480.739+24060%-722.402+4914%-1071.460+7337%23301.384-100%
Quick Ratio--15.72418.568-15%19.024-17%18.444-15%14.211+11%
Return On Assets---0.146-0.122-16%-0.095-35%-0.098-33%-0.098-33%
Return On Equity---0.160-0.135-16%-0.101-37%-0.103-35%-0.105-35%
Total Gains Per Share---0.004-0.001-79%0.002-324%0.001-550%0.001-743%
Usd Book Value--14854658.31016373962.269-9%13662525.404+9%12149815.728+22%8830019.455+68%
Usd Book Value Change Per Share---0.003-0.001-79%0.001-324%0.001-550%0.000-743%
Usd Book Value Per Share--0.0180.020-9%0.017+9%0.015+22%0.011+68%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.003-10%-0.001-53%-0.001-56%-0.001-68%
Usd Free Cash Flow---2289430.818-2137293.270-7%-1190362.619-48%-1079648.307-53%-831233.738-64%
Usd Free Cash Flow Per Share---0.003-0.003-7%-0.001-48%-0.001-53%-0.001-64%
Usd Free Cash Flow To Equity Per Share---0.003-0.001-80%0.002-250%0.001-556%0.000-2154%
Usd Market Cap24338381.040-35%32803904.88043297627.140-24%81348393.150-60%59133354.849-45%48443417.513-32%
Usd Price Per Share0.030-35%0.0410.054-24%0.101-60%0.073-45%0.060-32%
Usd Profit---2377960.911-2147651.532-10%-1325746.503-44%-1248592.097-47%-887009.821-63%
Usd Revenue--1274442.030810319.929+57%481045.545+165%393149.457+224%295004.944+332%
Usd Total Gains Per Share---0.003-0.001-79%0.001-324%0.001-550%0.000-743%
 EOD+3 -5MRQTTM+7 -27YOY+7 -275Y+10 -2410Y+11 -23

4.2. Fundamental Score

Let's check the fundamental score of Prescient Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.559
Price to Book Ratio (EOD)Between0-11.638
Net Profit Margin (MRQ)Greater than0-1.866
Operating Margin (MRQ)Greater than0-2.054
Quick Ratio (MRQ)Greater than115.724
Current Ratio (MRQ)Greater than110.256
Debt to Asset Ratio (MRQ)Less than10.087
Debt to Equity Ratio (MRQ)Less than10.095
Return on Equity (MRQ)Greater than0.15-0.160
Return on Assets (MRQ)Greater than0.05-0.146
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Prescient Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.050
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets24,762
Total Liabilities2,152
Total Stockholder Equity22,610
 As reported
Total Liabilities 2,152
Total Stockholder Equity+ 22,610
Total Assets = 24,762

Assets

Total Assets24,762
Total Current Assets21,392
Long-term Assets3,370
Total Current Assets
Cash And Cash Equivalents 6,418
Short-term Investments 12,020
Net Receivables 2,338
Other Current Assets 616
Total Current Assets  (as reported)21,392
Total Current Assets  (calculated)21,392
+/-0
Long-term Assets
Property Plant Equipment 3
Intangible Assets 3,367
Long-term Assets Other 0
Long-term Assets  (as reported)3,370
Long-term Assets  (calculated)3,370
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,086
Long-term Liabilities66
Total Stockholder Equity22,610
Total Current Liabilities
Accounts payable 1,940
Other Current Liabilities 146
Total Current Liabilities  (as reported)2,086
Total Current Liabilities  (calculated)2,086
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)66
Long-term Liabilities  (calculated)0
+/- 66
Total Stockholder Equity
Common Stock93,271
Retained Earnings -72,933
Accumulated Other Comprehensive Income 2,272
Total Stockholder Equity (as reported)22,610
Total Stockholder Equity (calculated)22,610
+/-0
Other
Cash and Short Term Investments 18,438
Common Stock Shares Outstanding 805,303
Liabilities and Stockholders Equity 24,762
Net Debt -6,418
Net Working Capital 19,306



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-31
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
162
0
0
0
0
0
0
0
2,798
0
0
1,384
1,384
5,143
5,143
4,282
4,282
2,608
2,608
1,904
1,904
1,774
1,774
1,634
1,634
2,379
2,379
4,148
4,148
4,342
4,342
4,183
4,183
2,548
2,548
3,708
3,708
2,214
2,214
3,244
3,244
1,200
1,200
1,751
1,750
808
808
1,182
1,182
720
720
1,568
1,568
1,350
1,350
702
702
260
260
62
62
0
0
0
0
1,626
1,626
5,280
5,280
5,646
5,646
4,892
4,892
6,203
6,202
13,835
13,835
13,469
13,469
12,230
12,230
10,947
10,947
9,991
9,991
8,489
8,489
15,007
15,007
13,394
13,394
0
12,072
0
22,625
0
20,967
0
19,057
17,618
17,618
25,885
25,885
28,108
28,108
24,762
24,76228,10828,10825,88525,88517,61817,61819,057020,967022,625012,072013,39413,39415,00715,0078,4898,4899,9919,99110,94710,94712,23012,23013,46913,46913,83513,8356,2026,2034,8924,8925,6465,6465,2805,2801,6261,626000062622602607027021,3501,3501,5681,5687207201,1821,1828088081,7501,7511,2001,2003,2443,2442,2142,2143,7083,7082,5482,5484,1834,1834,3424,3424,1484,1482,3792,3791,6341,6341,7741,7741,9041,9042,6082,6084,2824,2825,1435,1431,3841,384002,79800000001620000000000000000000000000000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150
0
0
0
0
0
0
0
2,787
0
0
0
1,370
0
0
0
4,255
0
0
0
1,875
0
0
0
1,592
0
0
0
3,873
0
0
0
4,183
0
0
0
3,686
0
0
0
3,230
0
0
0
1,745
0
0
0
1,180
0
0
0
1,563
0
0
0
698
0
0
0
62
0
0
0
0
0
1,626
0
3,935
0
2,578
0
1,525
0
2,836
0
10,467
10,102
10,102
8,861
8,861
7,577
7,577
6,622
6,622
5,121
5,121
11,639
11,639
10,026
10,026
8,705
8,705
19,257
19,257
17,598
17,598
15,688
15,688
14,247
14,247
22,514
22,514
24,739
24,739
21,392
21,39224,73924,73922,51422,51414,24714,24715,68815,68817,59817,59819,25719,2578,7058,70510,02610,02611,63911,6395,1215,1216,6226,6227,5777,5778,8618,86110,10210,10210,46702,83601,52502,57803,93501,62600000620006980001,5630001,1800001,7450003,2300003,6860004,1830003,8730001,5920001,8750004,2550001,3700002,78700000001500000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150
0
0
0
0
0
0
0
2,716
0
0
0
1,355
0
0
0
3,735
0
0
0
1,821
0
0
0
1,536
0
0
0
3,812
0
0
0
4,111
0
0
0
3,553
0
0
0
1,574
0
0
0
1,631
0
0
0
1,071
0
0
0
1,384
0
0
0
584
0
0
0
29
0
0
0
0
0
1,511
0
3,809
0
2,330
0
1,043
0
1,930
0
9,754
5,929
5,929
7,645
7,645
5,987
5,987
5,486
5,486
3,310
3,310
9,640
9,640
5,716
5,716
0
7,357
0
18,448
0
16,098
0
14,766
12,264
12,264
20,952
20,952
5,895
5,895
6,418
6,4185,8955,89520,95220,95212,26412,26414,766016,098018,44807,35705,7165,7169,6409,6403,3103,3105,4865,4865,9875,9877,6457,6455,9295,9299,75401,93001,04302,33003,80901,51100000290005840001,3840001,0710001,6310001,5740003,5530004,1110003,8120001,5360001,8210003,7350001,3550002,71600000001500000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,520
3,520
20
20
20
20
20
20
20
20
20
20
3,520
3,520
0
20
0
20
0
20
0
20
20
20
20
20
16,020
16,020
12,020
12,02016,02016,020202020202002002002003,5203,520202020202020202020203,5203,520000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71
0
0
14
15
170
170
510
273
363
363
49
49
84
84
18
17
26
26
57
56
96
96
26
26
52
52
77
72
598
598
1,577
1,577
113
113
61
61
94
94
58
58
77
77
134
134
598
598
44
44
29
29
15
15
0
0
0
0
115
115
127
127
194
194
428
211
863
863
664
645
569
569
1,080
1,058
1,464
1,464
985
939
1,651
1,651
1,748
1,748
660
660
1,060
1,060
655
655
1,239
1,239
768
768
78
1,718
1,408
1,408
2,577
2,577
2,338
2,3382,5772,5771,4081,4081,718787687681,2391,2396556551,0601,0606606601,7481,7481,6511,6519399851,4641,4641,0581,080569569645664863863211428194194127127115115000015152929444459859813413477775858949461611131131,5771,57759859872775252262696965657262617188484494936336327351017017015140071000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
10
241
5
5
5
5
5
5
38
38
27
27
5
5
107
107
46
5
214
214
57
5
178
178
79
79
121
121
53
53
118
118
51
51
101
101
45
45
99
99
70
69
25
25
18
18
0
0
0
0
0
115
0
127
55
55
54
271
43
43
49
69
83
83
116
137
105
105
39
177
0
140
1,631
231
599
131
0
268
0
134
1,185
241
702
135
1,641
245
0
134
0
246
616
616246013402451,6411357022411,185134026801315992311,631140017739105105137116838369494343271545555127011500000181825256970999945451011015151118118535312112179791781785572142145461071075527273838555555241101111000000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
0
0
0
0
0
0
10
0
0
0
14
0
0
0
27
0
0
0
29
0
0
0
42
0
0
0
275
0
0
0
0
0
0
0
21
0
0
0
15
0
0
0
6
0
0
0
2
0
0
0
5
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
1,344
0
3,067
0
3,367
0
3,367
0
3,368
0
3,368
0
3,369
0
3,370
0
3,369
0
3,368
0
3,368
0
3,367
0
3,367
0
3,369
0
3,369
0
3,368
3,372
3,372
3,371
3,371
3,370
3,370
3,370
3,3703,3703,3703,3713,3713,3723,3723,36803,36903,36903,36703,36703,36803,36803,36903,37003,36903,36803,36803,36703,36703,06701,3440000000000040005000200060001500021000000027500042000290002700014000100000000120000000000000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
0
0
0
0
0
0
10
0
0
14
14
24
24
27
27
31
31
29
29
33
33
42
42
35
35
275
275
250
250
0
0
9
9
21
21
22
22
15
15
8
8
6
6
5
5
2
2
2
2
5
5
5
5
4
4
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
2
2
3
3
2
2
2
2
1
1
0
0
0
0
2
2
2
2
1
1
5
5
4
4
3
3
3
3334455112222000011222233221111000000000000000033445555222255668815152222212199002502502752753535424233332929313127272424141400100000000120000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,344
1,344
3,067
3,067
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
0
3,367
0
3,367
0
3,367
0
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,3673,3673,3673,3673,3673,3673,3673,36703,36703,36703,36703,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,0673,0671,3441,34400000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,344
1,344
3,067
3,067
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,0673,0671,3441,34400000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137
0
0
0
0
0
0
0
120
0
0
108
108
627
627
668
668
436
436
448
448
536
536
680
680
525
525
511
511
2,649
2,649
1,353
1,353
1,639
1,639
1,681
1,681
1,642
1,642
1,476
1,476
785
785
1,677
1,677
1,532
1,532
1,786
1,786
1,237
1,237
1,289
1,289
1,202
1,202
1,534
1,534
1,409
1,409
1,849
1,849
0
0
0
0
35
35
253
253
438
438
441
441
618
618
823
823
232
232
445
445
280
273
552
552
512
501
686
686
663
663
0
884
0
263
0
540
0
431
856
856
1,031
1,082
2,027
2,033
2,152
2,1522,0332,0271,0821,0318568564310540026308840663663686686501512552552273280445445232232823823618618441441438438253253353500001,8491,8491,4091,4091,5341,5341,2021,2021,2891,2891,2371,2371,7861,7861,5321,5321,6771,6777857851,4761,4761,6421,6421,6811,6811,6391,6391,3531,3532,6492,6495115115255256806805365364484484364366686686276271081080012000000001370000000000000000000000000000000000
   > Total Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137
0
0
0
0
0
0
0
120
0
0
108
108
627
627
668
668
436
436
448
448
536
536
680
680
525
525
511
511
2,649
2,649
1,315
1,353
1,639
1,639
1,660
1,660
1,622
1,622
1,469
1,468
771
771
373
373
1,532
1,532
1,786
1,786
397
397
392
392
1,202
1,202
1,534
1,534
1,409
1,409
1,849
1,849
0
0
0
0
35
35
253
253
438
438
439
439
618
618
822
822
232
232
441
441
274
273
544
544
501
501
668
668
641
641
864
864
240
240
515
515
390
390
809
809
1,031
1,031
2,027
2,027
2,086
2,0862,0272,0271,0311,031809809390390515515240240864864641641668668501501544544273274441441232232822822618618439439438438253253353500001,8491,8491,4091,4091,5341,5341,2021,2023923923973971,7861,7861,5321,5323733737717711,4681,4691,6221,6221,6601,6601,6391,6391,3531,3152,6492,6495115115255256806805365364484484364366686686276271081080012000000001370000000000000000000000000000000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,508
0
0
0
0
0
0
0
1,035
0
0
0
1,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
56
56
0
0
0
20
0
0
0
157
0
0
0
166
0
0
0
0
0
0
0
0
0
000000000166000157000200005656002000000000000000000001,1000001,03500000001,5080000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56
56
0
0
0
0
0
0
0
157
0
0
0
166
0
0
0
0
0
0
0
0
0
00000000016600015700000005656000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104
108
627
627
139
139
0
0
365
364
0
0
0
0
328
328
0
260
259
259
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
337
337
0
0
165
165
0
170
204
204
0
0
0
0
0
0
35
35
217
217
425
425
397
397
605
605
309
309
209
209
341
341
213
213
243
243
403
403
393
393
528
528
480
662
180
180
233
233
293
293
505
663
856
856
1,778
1,824
1,940
1,9401,8241,77885685666350529329323323318018066248052852839339340340324324321321334134120920930930960560539739742542521721735350000002042041700165165003373370000000000000000002592592600328328000036436500139139627627108104000000000000000000000000000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137
0
0
0
0
0
0
0
120
0
0
4
4
0
0
528
528
436
436
84
84
536
536
680
680
197
197
511
251
2,389
2,389
1,314
988
1,639
1,639
1,660
669
1,622
1,622
1,469
1,468
771
771
373
373
88
88
278
278
60
60
391
392
71
71
498
329
100
100
749
749
0
0
0
0
0
0
35
35
13
13
42
42
13
13
514
514
23
23
100
100
61
61
37
301
0
98
42
275
0
113
182
45
0
60
45
116
0
97
304
146
175
175
248
203
146
1462032481751751463049701164560045182113027542980301376161100100232351451413134242131335350000007497491001003294987171392391606027827888883733737717711,4681,4691,6221,6226691,6601,6391,6399881,3142,3892,389251511197197680680536536848443643652852800440012000000001370000000000000000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
0
0
0
8
0
0
0
1,305
0
0
0
0
0
0
0
897
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
4
0
0
0
8
0
0
0
18
0
22
0
20
0
22
0
25
0
41
47
47
0
51
0
6
66
66605104747410250220200220180008000400000002000000000000000000089700000001,3050008000210000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38
0
0
0
21
21
20
20
8
8
14
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
0
0
0
0
1
1
4
4
6
6
8
8
11
11
18
18
22
22
20
20
22
22
25
25
41
41
47
47
51
51
6
6
0
066515147474141252522222020222218181111886644110000330000000000000000000000000000141488202021210003800000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24
0
0
0
0
0
0
0
2,678
0
0
1,277
1,277
4,515
4,515
3,615
3,614
2,172
2,172
1,456
1,456
1,238
1,238
954
954
1,854
1,854
3,637
3,637
1,694
1,694
2,830
2,830
909
909
2,027
2,027
572
572
1,768
1,768
414
414
73
73
0
0
0
-604
0
0
279
279
148
148
0
-832
0
0
0
-1,787
0
0
0
0
1,591
1,591
5,027
5,027
5,208
5,208
4,451
4,450
5,585
5,585
13,013
13,013
13,237
13,237
11,785
11,785
10,667
10,667
9,439
9,439
7,977
7,977
14,321
14,321
12,731
12,731
0
11,188
0
22,363
0
20,427
0
18,626
16,762
16,762
22,673
24,803
23,933
26,075
22,610
22,61026,07523,93324,80322,67316,76216,76218,626020,427022,363011,188012,73112,73114,32114,3217,9777,9779,4399,43910,66710,66711,78511,78513,23713,23713,01313,0135,5855,5854,4504,4515,2085,2085,0275,0271,5911,5910000-1,787000-832014814827927900-60400073734144141,7681,7685725722,0272,0279099092,8302,8301,6941,6943,6373,6371,8541,8549549541,2381,2381,4561,4562,1722,1723,6143,6154,5154,5151,2771,277002,6780000000240000000000000000000000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,707
0
0
0
0
0
0
0
7,472
0
0
8,353
8,353
12,980
12,980
12,984
12,984
12,984
12,984
13,473
13,473
15,149
15,149
16,106
16,106
19,361
19,361
22,753
22,753
22,756
22,756
25,945
25,945
26,195
26,195
29,667
29,667
30,378
30,378
31,973
31,973
31,973
31,973
31,973
31,973
31,973
31,973
32,642
32,642
33,334
33,334
35,104
35,104
35,225
35,225
35,298
35,298
36,077
36,077
36,216
36,216
36,216
36,216
36,216
36,216
38,521
38,521
42,497
42,497
43,693
43,693
43,994
43,994
45,771
45,771
54,277
54,277
55,497
55,497
55,497
55,497
55,497
55,497
55,571
55,571
55,574
55,574
63,930
63,930
63,930
63,930
63,930
63,930
76,640
76,640
76,671
76,671
76,997
76,997
77,264
77,264
87,952
87,952
93,246
93,246
93,271
93,27193,24693,24687,95287,95277,26477,26476,99776,99776,67176,67176,64076,64063,93063,93063,93063,93063,93063,93055,57455,57455,57155,57155,49755,49755,49755,49755,49755,49754,27754,27745,77145,77143,99443,99443,69343,69342,49742,49738,52138,52136,21636,21636,21636,21636,21636,21636,07736,07735,29835,29835,22535,22535,10435,10433,33433,33432,64232,64231,97331,97331,97331,97331,97331,97331,97331,97330,37830,37829,66729,66726,19526,19525,94525,94522,75622,75622,75322,75319,36119,36116,10616,10615,14915,14913,47313,47312,98412,98412,98412,98412,98012,9808,3538,353007,47200000001,7070000000000000000000000000000000000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
655
0
0
0
0
0
0
0
-12
0
0
0
-15
0
0
0
-8
0
0
0
-34
0
0
0
-51
0
0
0
-109
0
0
0
-467
0
0
0
186
0
0
0
288
0
0
0
288
0
0
0
288
0
0
0
478
0
0
0
534
0
0
0
553
0
0
0
0
0
0
0
43
0
564
0
576
0
556
0
609
0
637
0
729
0
791
0
883
0
925
0
1,100
0
1,187
0
716
0
969
0
1,264
0
1,748
1,950
1,950
0
2,130
0
2,142
2,272
2,2722,14202,13001,9501,9501,74801,2640969071601,18701,1000925088307910729063706090556057605640430000000553000534000478000288000288000288000186000-467000-109000-51000-34000-8000-15000-1200000006550000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
655
0
0
0
0
0
0
0
12
0
0
0
15
0
0
0
8
0
0
0
34
0
0
0
51
0
0
0
109
0
0
0
467
0
0
0
0
0
0
0
0
0
0
0
79
0
0
0
79
0
0
0
96
0
0
0
96
0
0
0
0
0
0
0
0
0
0
0
473
0
564
0
0
0
556
0
0
637
0
729
729
791
0
883
883
925
0
1,100
206
1,187
1,187
716
716
969
969
1,264
1,264
1,748
1,748
1,950
1,950
-22,673
-22,673
-23,933
-23,933
0
0-23,933-23,933-22,673-22,6731,9501,9501,7481,7481,2641,2649699697167161,1871,1872061,10009258838830791729729063700556000564047300000000000960009600079000790000000000046700010900051000340008000150001200000006550000000000000000000000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue2,428
Cost of Revenue-2
Gross Profit2,4262,426
 
Operating Income (+$)
Gross Profit2,426
Operating Expense-9,884
Operating Income-9,886-7,458
 
Operating Expense (+$)
Research Development6,222
Selling General Administrative1,353
Selling And Marketing Expenses2,309
Operating Expense9,8849,884
 
Net Interest Income (+$)
Interest Income459
Interest Expense-0
Other Finance Cost-0
Net Interest Income459
 
Pretax Income (+$)
Operating Income-9,886
Net Interest Income459
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,373-10,399
EBIT - interestExpense = -9,886
-9,373
-7,005
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-9,886-9,373
Earnings Before Interest and Taxes (EBITDA)-9,884
 
After tax Income (+$)
Income Before Tax-9,373
Tax Provision-0
Net Income From Continuing Ops-7,005-9,373
Net Income-7,005
Net Income Applicable To Common Shares-7,005
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses9,886
Total Other Income/Expenses Net513-459
 

Technical Analysis of Prescient Therapeutics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Prescient Therapeutics Ltd. The general trend of Prescient Therapeutics Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Prescient Therapeutics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Prescient Therapeutics Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.057 < 0.066 < 0.066.

The bearish price targets are: 0.05 > 0.048 > 0.048.

Tweet this
Prescient Therapeutics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Prescient Therapeutics Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Prescient Therapeutics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPrescient Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Prescient Therapeutics Ltd. The current adx is .

Prescient Therapeutics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Relative Strength Index (RSI) ChartPrescient Therapeutics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Stochastic Oscillator ChartPrescient Therapeutics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Commodity Channel Index (CCI) ChartPrescient Therapeutics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) ChartPrescient Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Williams %R ChartPrescient Therapeutics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Average True Range (ATR) ChartPrescient Therapeutics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily On-Balance Volume (OBV) ChartPrescient Therapeutics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd Daily Money Flow Index (MFI) ChartPrescient Therapeutics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Prescient Therapeutics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Prescient Therapeutics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Prescient Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.050
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Prescient Therapeutics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Prescient Therapeutics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Prescient Therapeutics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Prescient Therapeutics Ltd

I send you an email if I find something interesting about Prescient Therapeutics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Prescient Therapeutics Ltd.

Receive notifications about Prescient Therapeutics Ltd in your mailbox!